BHSRX BlackRock Health Sciences Opps R Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Amgen (NASDAQ:AMGN).

The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

The average market capitalization across the BlackRock Health Sciences Opps R MF is 252.83B. The market cap for tickers in the group ranges from 143.36B to 651.91B. LLY holds the highest valuation in this group at 651.91B. The lowest valued company is DHR at 143.36B.

The average weekly volume growth across all stocks in the BlackRock Health Sciences Opps R MF was 19%. For the same stocks of the MF, the average monthly volume growth was -17% and the average quarterly volume growth was -33%